文章摘要
赵岩松,洪兰,叶桦.美国与欧盟药物研制中的儿童用药研究计划初探[J].中国药事,2017,(4):358-363
美国与欧盟药物研制中的儿童用药研究计划初探
Exploration of Pediatric Study / Investigation Plan in Drug Research and Development in the US and the EU
投稿时间:2016-09-13  
DOI:10.16153/j.1002-7777.2017.04.003
中文关键词: 儿童用药研究计划  药品研制  政策法规
英文关键词: pediatric study plan  drug research and development  regulation and guideline
基金项目:
作者单位E-mail
赵岩松 复旦大学药学院, 上海 201203
罗氏中国投资有限公司, 上海 201203 
 
洪兰 复旦大学药学院, 上海 201203  
叶桦 复旦大学药学院, 上海 201203 yehua@fudan.edu.cn 
摘要点击次数: 1111
全文下载次数: 859
中文摘要:
      目的:详细介绍了美国、欧盟法规中的儿童用药研发计划,希望为我国的儿童用药法规提供参考和借鉴。方法:分析、对比美国和欧盟的儿童用药研发计划,同时对我国目前的儿童用药政策作了简要介绍。结果与结论:我国的儿童用药法规可以借鉴美国与欧盟的经验,逐步推进儿童用药研发计划的做法。
英文摘要:
      Objective: To present the FDA pediatric study plan and EMA pediatric investigation plans in detail, to provide references for pediatric regulations in China. Method: The pediatric study plans in the US and the EU were analyzed and compared. The pediatric regulations and guidelines in China were briefly introduced. Results and Conclusion: China may learn experiences from the US and the EU, so as to gradually promote the pediatric research plan.
查看全文   查看/发表评论  下载PDF阅读器
关闭